Showing results (2131-2140 of 6,739) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|June 20, 2019
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancerYan Jiao, Yanqing Li, Songyang Liu, et al.Oncotargets and Therapy|June 20, 2019
CD48 is a key molecule of immunomodulation affecting prognosis in gliomaCunyi Zou, Chen Zhu, Gefei Guan, et al.Oncotargets and Therapy|June 20, 2019
HnRNPL promotes Wilms tumor progression by regulating the p53 and Bcl2 pathwaysXin Luo, Changkai Deng, Feng Liu, et al.Oncotargets and Therapy|June 20, 2019
Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cellsXiuhe Lv, Zhen Chen, Shaohua Li, et al.Oncotargets and Therapy|June 27, 2019
High expression of GMⅡ is associated with poor prognosis of gastric cancer patientsShasha Zhu, Yao Li, Wei Xiao, et al.Oncotargets and Therapy|June 27, 2019
m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathwaysRu Deng, Yikan Cheng, Shubiao Ye, et al.Oncotargets and Therapy|June 27, 2019
LINC00339 promotes growth and invasiveness of hepatocellular carcinoma by the miR-1182/SKA1 pathwayJun Xiao, Haibo Yu, Zhongwu MaOncotargets and Therapy|July 11, 2019
MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)Arushi Khurana, Danielle A ShaferOncotargets and Therapy|February 17, 2022
Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN StageZhihong Wang, Peng Tang, Surong Hua, et al.Oncotargets and Therapy|March 14, 2022
miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]Pageof 674